| VDAs | Vascular disrupting agents |
| CA4P | Combretastatin A-4 phosphate |
| OXi | OXi4503 |
| Anti-PD-1 | Anti-programmed death 1 |
| Anti-PD-L1 | Anti-programmed death 1 ligand |
| Anti-CTLA-4 | Anti-cytotoxic T-lymphocyte-associated protein 4 |
| APCs | Antigen presenting cells |
| ICPs | Immune checkpoint proteins |
| DAMPs | Damage associated molecular patterns |
| HIF | Hypoxia inducible factor |
| i.p. | Intraperitoneal |
| TGT5 | Tumor growth time 5; days taken to grow to 5 times treatment volume |
| CIs | Checkpoint Inhibitors |
| SEM | Standard Error of the Mean |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.